A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly.

  title={A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly.},
  author={A. de Paiva and B. Poulain and G. Lawrence and C. Shone and L. Tauc and J. Dolly},
  journal={The Journal of biological chemistry},
  volume={268 28},
Botulinum neurotoxin type A consists of a disulfide-linked light and heavy chain, with an intradisulfide present within the C-terminal half of the latter. The functional consequences of reducing these bonds and alkylating the thiols were investigated. Modification of free cysteine residues had no effect on the toxicity in mouse bioassays or on acetylcholine release in the mouse nerve-diaphragm and the buccal ganglion of Aplysia californica. However, reduction of the toxin prior to alkylation… Expand
Inhibition of botulinum neurotoxins interchain disulfide bond reduction prevents the peripheral neuroparalysis of botulism.
The present data demonstrate the essential role of the thiOREDoxin-thioredoxin reductase system in reducing the interchain disulfide during the nerve intoxication mechanism of all serotypes and its inhibitors should be considered for a possible use to prevent botulism and for treating infant botulisms. Expand
Double anchorage to the membrane and intact inter‐chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons
This study found that the neurotoxin has to be bound to the membrane via at least two anchorage sites in order for a productive low‐pH induced structural change to take place, and proposed a stepwise sequence of molecular events that lead from toxin binding to membrane insertion. Expand
Light Chain of Botulinum A Neurotoxin Expressed as an Inclusion Body from a Synthetic Gene Is Catalytically and Functionally Active
A synthetic gene is constructed for the LC of the botulinum neurotoxin serotype A (BoNT/A), overexpressed it in Escherichia coli, and purified the gene product from inclusion bodies to make available a large amount of the biologically active toxin fragment in a soluble and stable form. Expand
Novel Chimeras of Botulinum Neurotoxins A and E Unveil Contributions from the Binding, Translocation, and Protease Domains to Their Functional Characteristics*
Proof of principle is provided for tailoring the pharmacological properties of these toxins by protein engineering. Expand
The role of the single interchains disulfide bond in tetanus and botulinum neurotoxins and the development of antitetanus and antibotulism drugs
Ebselen and PX‐12, two TrxR‐Trx specific drugs previously used in clinical trials in humans, satisfy all the requirements for clinical tests aiming at evaluating their capacity to effectively counteract human and animal botulism arising from intestinal toxaemias such as infantBotulism. Expand
Pharmacology of Botulinum Neurotoxins: Exploitation of Their Multifunctional Activities as Transmitter Release Inhibitors and Neuron-Targeted Delivery Vehicles
Quantal transmitter release from nerves is inhibited by all seven serotypes (A–G) of botulinum neurotoxin (BoNT), with some subtle but functional differences. Commonalities and dissimilarities inExpand
Productive and non‐productive binding of botulinum neurotoxin A to motor nerve endings are distinguished by its heavy chain
It is deduced that botulinum neurotoxin bound to heavy chain‐susceptible sites has a different fate, presumably due to trafficking via another route, and thus would be inefficient in causing neuroparalysis. Expand
Hsp90 and Thioredoxin‐Thioredoxin Reductase enable the catalytic activity of Clostridial neurotoxins inside nerve terminals
Trx‐TrxR and Hsp90 are rational targets to design pan‐inhibitors against Botulinum and Tetanus neurotoxins and represent a rational target for the development of mechanism‐based antitoxins. Expand
Expression and characterisation of the heavy chain of tetanus toxin: reconstitution of the fully-recombinant dichain protein in active form.
The fully-recombinant toxin produced spastic paralysis in mice characteristic of the blockade of central inhibitory synapses, revealing that it undergoes axonal transport to the spinal cord, like the native toxin but with a reduced efficacy. Expand
Targeted delivery into motor nerve terminals of inhibitors for SNARE‐cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin
This demonstrated versatility of TDC for nonviral cargo transfer into cholinergic nerve endings has unveiled its potential for direct delivery of functional targets into motor nerve endings. Expand